C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study

BACKGROUND: Poor response to anti-tumour necrosis factor biologicals like infliximab (IFX) is observed in patients with ulcerative colitis (UC), which may lead to prolonged morbidity and waste of medical resources. We aimed to look for potential biomarkers of response to IFX in patients with UC who...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Gastroenterol
Main Authors: Iwasa, Ryota, Yamada, Akihiro, Sono, Koji, Furukawa, Ryuichi, Takeuchi, Ken, Suzuki, Yasuo
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2015
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535387/
https://ncbi.nlm.nih.gov/pubmed/26271624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0333-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker